These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 428235)

  • 21. Morphometric studies of the endometrium, the fallopian tube and the corpus luteum during contraception with the 300 micrograms norethisterone (NET) minipill.
    Kim-Björklund T; Landgren BM; Johannisson E
    Contraception; 1991 May; 43(5):459-74. PubMed ID: 1914459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of continuous daily administration of 0.5 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone, pregnanediol and total oestrogens.
    Larsson-Cohn U; Johansson ED; Wide L; Gemzell C
    Acta Endocrinol (Copenh); 1970 Feb; 63(2):216-24. PubMed ID: 5468622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of norethindrone and some other synthetic gestagens upon the peripheral plasma levels of progesterone and estradiol during early, human pregnancy.
    Nygren KG; Johansson ED
    Acta Obstet Gynecol Scand; 1975; 54(1):57-63. PubMed ID: 46683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence of ovulation in women receiving the injectable contraceptive norethisterone oenanthate.
    Fotherby K; Howard G; Shrimanker K; Elder M; Bye PG
    Contraception; 1978 Nov; 18(5):535-42. PubMed ID: 729379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids.
    Stanczyk FZ; Brenner PF; Mishell DR; Ortiz A; Gentzschein EK; Goebelsmann U
    Contraception; 1978 Dec; 18(6):615-33. PubMed ID: 750188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrastructure of human uterine epithelium at the time of implantation after postovulatory administration of norethindrone.
    Nilsson O; Nygren KG
    Ups J Med Sci; 1974; 79(2):65-71. PubMed ID: 4837833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
    Kekkonen R; Lähteenmäki P; Luukkainen T; Tuominen J
    Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
    Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of injectable biodegradable contraceptive system.
    Beck LR; Ramos RA; Flowers CE; Lopez GZ; Lewis DH; Cowsar DR
    Am J Obstet Gynecol; 1981 Aug; 140(7):799-806. PubMed ID: 7020421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating levels of norethindrone in women with a single silastic implant.
    Goyal V; Joshi UM; Naik VK
    Contraception; 1978 Apr; 17(4):375-82. PubMed ID: 648158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a low-dose monthly injectable contraceptive system: II. Pharmacokinetic and pharmacodynamic studies.
    Díaz-Sánchez V; Garza-Flores J; Jimenéz-Thomas S; Rudel HW
    Contraception; 1987 Jan; 35(1):57-68. PubMed ID: 3568660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of biodegradable norethisterone implants as a 6-month contraceptive system.
    Rivera R; Gaitan JR; Ortega M; Flores C; Hernandez A
    Fertil Steril; 1984 Aug; 42(2):228-32. PubMed ID: 6745456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproductive endocrine effects of intranasal administration of norethisterone to adult female rhesus monkeys (Macaca mulatta).
    Puri V; David GF; Dubey AK; Puri CP; Anand Kumar TC
    J Reprod Fertil; 1986 Jan; 76(1):215-20. PubMed ID: 3944792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endometrial histology and progesterone levels in women using norethindrone acetate implants for contraception.
    Takkar D; Jeyaseelan S; Kinra G; Laumas KR; Hingorani V
    Contraception; 1978 Feb; 17(2):103-13. PubMed ID: 630880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaginal progesterone for contraception.
    Victor A; Jackanicz TM; Johansson ED
    Fertil Steril; 1978 Dec; 30(6):631-5. PubMed ID: 729823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of an improved injectable microcapsule contraceptive system.
    Beck LR; Flowers CE; Pope VZ; Wilborn WH; Tice TR
    Am J Obstet Gynecol; 1983 Dec; 147(7):815-21. PubMed ID: 6650605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Release of norethisterone from a bioabsorbable implant in female bonnet monkeys (Macaca radiata).
    Maitra A; Joshi UM; Kholkute SD; Munshi SR; Gupta GN; Tejuja S
    Contraception; 1980 Feb; 21(2):165-73. PubMed ID: 6768491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative evaluation of the safety and contraceptive effectiveness of 65 mg and 100 mg of 90-day norethindrone (NET) injectable microspheres: a multicenter study.
    Grubb GS; Welch JD; Cole L; Goldsmith A; Rivera R
    Fertil Steril; 1989 May; 51(5):803-10. PubMed ID: 2523322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.